☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Lansoprazole suspension discontinued

According to the National electronic Library for Medicines, lansoprazole suspension (Zoton®) is to be discontinued.

The place in therapy for the suspension formulation has always been limited to patients who struggled to swallow a solid dosage form like a tablet or a capsule. The FasTab® formulation of lansoprazole would appear to be a cost-effective and suitable alternative. The Drug Tariff for August 2007 lists current prices as follows:

  • Lansoprazole 30mg orodispersible tablets (28) - £11.00
  • Lansoprazole 30mg gastro-resistant granules sachets (8) - £33.97

Action: Clinicians should be aware of this product discontinuation and ensure prescriptions are altered to a suitable alternative before supply issues arise.

Share 'Lansoprazole suspension discontinued' by emailShare 'Lansoprazole suspension discontinued' on FacebookShare 'Lansoprazole suspension discontinued' on TwitterShare 'Lansoprazole suspension discontinued' on LinkedInShare 'Lansoprazole suspension discontinued' on reddit


No Comments to “Lansoprazole suspension discontinued”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.